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Abstract 
Purpose:  To derive a clinically-practical margin formula between clinical target volume (CTV) and planning target 
volume (PTV) for single-fraction stereotactic radiosurgery (SRS).Methods:  In previous publications on the margin 
between the CTV and the PTV, a Gaussian function with zero mean was assumed for the systematic error and the ma-
chine systematic error was completely ignored. In this work we adopted a Dirac delta function for the machine system-
atic error for a given machine with nonzero mean systematic error. Mathematical formulas for calculating the 
CTV-PTV margin for single-fraction SRS treatments were proposed. Results:  Margins for single fraction treatments 
were derived such that the CTVs received the prescribed dose in 95% of the SRS patients. The margin defined in this 
study was machine specific and accounted for nonzero mean systematic error. The differences between our formulas 
and a previously published formula were discussed. Conclusion: Clinical margin formulas were proposed for deter-
mining the margin between the CTV and the PTV in SRS treatments. Previous margin’s recipes, being derived specifi-
cally for conventional treatments, may be inappropriate for single-fraction SRS and could result in geometric miss of 
the target and even treatment failure for machines possessing of large systematic errors. 
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1. Introduction  
Driven by rapid advances in on-board imaging technol-
ogy, image-guided single-fraction stereotactic radiosur-
gery (SRS) has become increasingly popular for the 
treatment of both primary brain tumors and solitary brain 
metastases today. Its benefits and downsides have been 
extensively studied in the theoretical papers [1, 2]. Dic-
tated by its fractionation scheme, a single-fraction SRS 
treatment has no inter-fraction setup-error distribution 
for a specific patient, a phenomenon that only exists in 
multi-fraction treatments for a specific patient. Because 
of its high prescription dose, one needs to make every 
effort to minimize the setup errors prior to the initiation 
of a single fraction treatment. By enhancing the geomet-
ric accuracy of radiation therapy (RT), improvements 
may be achieved in terms of tumor control probability, 
reduction in toxicity, and conformal avoidance by reduc-
tion of individualized planning target volume (PTV) 
margins. To minimize setup errors, historically, SRS 
frames have been used to replicate the initial simulation 
geometry at the time of therapy. Lately, medical linear 
accelerator (linac) manufacturers have developed inte-
grated imaging systems to improve and facilitate the 
visualization of patient anatomy [4-5]. These imaging 
systems often use the accelerator isocenter (iso) as the 
iso of their system. No matter how advanced the tech-
nologies are, there are always machine systematic errors 
present, which are defined as the geometric misalign-
ment between the accelerator iso and the imaging system 
iso. This misalignment will ultimately affect the accura-
cy of the replication of a simulation. This intrinsic hard-
ware uncertainty should be incorporated into the design  
of the CTV-PTV margin. 
 
While the estimation of the CTV-PTV margin has been 
previously studied for conventional fractionation [6-10], 
the methodology is inappropriate for single-fraction 
treatments. Specifically the systematic and random re-
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sidual setup errors in conventional fraction treatments are 
not directly applicable to single-fraction treatments. In 
conventional fraction treatments, the random setup error 
“blurs” the dose distribution isotropically, but the sys-
tematic error shifts the dose distribution unidirectionally.   
 
Though the margin formula was derived almost twenty 
years ago [8], it is still the only recipe being widely im-
plemented clinically today. However, a flaw of the deri-
vation [8] was the zero mean assumption of the system-
atic and random set up errors. Owing to this, the validity 
of its natural extension to modern linacs with multiple 
rotation axes and x-ray source is being challenge. In a 
single-fraction treatment, both machine systematic and 
patient random setup errors displace the dose distribution 
with respect to the planned distribution.  Hence, the 
purpose of this study is to determine the characteristics 
and magnitude of the uncertainty and analytically derive 
the CTV-PTV margin using a model-based approach.   
In this model, the nonzero systematic error for a specific 
machine is explicitly included in the CTV-PTV margin.  
To the best of our knowledge, this type of study has not 
been previously addressed in the literature.   
 
In this paper, we assume two coordinate systems: one 
whose origin is affixed to the iso of the cone-beam com-
puted tomography (CBCT) and the other one whose 
origin is placed at the linac’s iso. For image guided SRS 
(IG-SRS) cases, the planning CT (PCT) iso is at the iso 
of the linac. Upon successful completion of CBCT-PCT 
image registration, one assumes that the CBCT origin 
coincides with that of the PCT or linac. However, due to 
the limitations in the alignment accuracy between the 
linac and CBCT isocenters, CT image quality, and hu-
man factors, there exist a number of uncertainties in the 
patient setup process. These uncertainties can be classi-
fied into two types: (1) systematic errors, which are 
mainly caused by, for example, image quality and iso 
accuracy limitations and (2) residual setup errors, such as 
4 degrees-of-freedom (DOF) couch (three translations 
and one rotation) which precludes the correction of all 6 
DOF errors (three translations and three rotations). It 
should be noted that deformation is ignored here. There-
fore, residual errors always exist in the setup. Among the 
two, the machine systematic errors, such as iso 
discrepency, are machine specific and nearly pa-
tient-independent, whereas the residual setup errors vary 
from patient to patient.  In our study, the machine sys-
tematic error refers specifically to the iso discrepancy 
between the linac and CBCT, which is assumed to be 
zero in the treatment planning process.  
 
Systematic errors are not a new concept and have been 
reported in the literature
 
[6-10]. However, there are some 
differences in the definition of systematic errors between 
this paper and previous publications. In a previous study 
[8], the systematic errors were designated as the “setup 
error at the scanner, delineation error, and motion error,” 
which are different from the errors in iso discrepancy 
described in this paper. In our paper, we disregard those 
non-IGRT related systematic errors because they are not 
in the scope of our study. For example, variation among 
physician CTVs is irrelevant to our calculation assump-
tions as long as the CTV contour encompasses all the 
gross tumor volume and microscopic extensions of the 
disease. Also, the same authors assumed that their sys-
tematic errors were stochastic over a group of patients. In 
the paper presented here, iso differences are independent 
of patients and specific to machines. In another published 
report, the mean systematic error was described as the 
average for all patients in a given group. It was also as-
sumed that one might eliminate this systematic error by 
“some subtraction” method (for example, couch shift) 
[11]. Therefore, the margin definition there did not in-
clude any information on the mean setup error. Addi-
tionally, from a technical point of view, this method is 
un-implementable for sub-millimeter systematic error. In 
this paper, we will discuss the iso differences that cannot 
be obtained by the average method given in previous 
publications. We demonstrate a simple method to include 
this small systematic error in the margin formula.  
 
For a comparison, similar to a previous work [8] the 
margin formula for all machines and the whole popula-
tion (for single-fraction treatment) is derived in this pa-
per. Unlike the previous publications, which assumed 
that the “mean value” can be eliminated and conse-
quently omitted in the margin formula. This “mean val-
ue” is included in our formulas because most IGRT sys-
tems are not capable of applying shifts at a 
sub-millimeter scale.  
 
The paper is organized in the following way: In Section 
II (Methods), the relation between the probabilities that 
patients receive the prescribed dose and margins are de-
rived for 3D expansion. Margin formulas for a group of 
machines and whole population are also derived here.  
In Section III (Results), the margin formulas for 3D ex-
pansions are given for cases in which the CTVs receive 
the prescribed dose in 95% of the treated patients. The 
differences between our margin formula and previously 
published one are also addressed. In Section IV, our 
formulas are discussed in greater detail and conclusions 
are given thereafter. 
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2. Methods  
As mentioned earlier, in our approach, the “mean error” 
is included in our formula. Figure 1 explains why the 
margin for cases with nonzero systematic error is differ-
ent from that for cases with zero systematic error. Here, 
AB and CD represent the CTVs in the PCT image and 
the corresponding verification CBCT image, respective-
ly. Figure 1a shows that the iso of the CBCT coincides 
with that of the linac. Considering this, we only need to 
add a suitable margin around the CTV in PCT to account 
for the possible random setup errors, giving the PTV, 
indicated by EF in Figure 1a.  However, if these two 
isocenters are not coincident (Fig. 1b), the two images 
are actually misaligned although they appear matched on 
the imaging console. As a result AB (CTV in the PCT) 
and CD (CTV in the CBCT) are mis-registered.  To 
correct this mismatch, one can apply a couch shift, as has 
been described in a previous study [11]. However, after 
couch shifts, submillimeter mismatch may still remain. 
To include or eliminate this residual misalignment in our 
treatment planning process, we can adjust the CBCT iso 
to exactly match the radiation iso (or vice versa; green 
line in Fig.1b). However, submillimeter adjustments are 
not technically feasible. Alternatively, we can determine 
a proper margin to account for the subtle difference and 
correct for the misalignment. In Fig.1b, GH represent the 
PTVs, taking into account for the isocenter misalignment 
and residual setup error.  Even if these two isocenters 
are coincident, it would be still interesting to see the 
margin differences between the cases with and without 
isocenter discrepancies. )(xDCT

represents the dose dis-
tribution in the PCT, calculated with the
 
origin of the 
coordinate system at the linac isocenter.  Due to com-
bined random setup and systematic errors, there is a dis-
placement between the radiation and patient (CBCT) 
isocenters. This displacement, denoted as V

,is a 
three-dimensional (3D) vector 
( linacCBCT soIsoIV

 ). For intracranial SRS treat-
ment, internal organ movement is considered negligible.  
In the CBCT frame of reference, i.e, the patient frame of 
reference, the patient dose distribution can be expressed 
as:  
)()( VxDxD CTCBCT

                  (1) 
 
The patient dose at point x

 in the CBCT image is the 
same as the dose in the PCT at point Vx

 because of 
the shift in an actual patient (Fig. 1b).  In other words, 
each point in the PTV is shifted by V

 from the radia-
tion isocenter. Vector V

 contains two components, 
systematic shift ( sV

) and random shift ( rV

): 
                                   
)2(.rVsVV

                                  
  
 
 
 
 
 
 
 
 
 
Figures 1(a) and 1(b):  Illustration shows that the margin 
for cases with nonzero systematic error is different from 
that for cases with zero systematic error. Here, AB and CD 
represent the CTVs in the PCT and the corresponding 
CBCT, respectively. Fig. 1(a) shows that the isocenter of the 
CBCT is coincident with that of radiation.  EF is the PTV.  
Fig. 1(b) shows that these two isocenters are not coincident. 
The two images are actually misaligned although they ap-
pear matched on the imaging console.  Now AB and CD 
are misaligned.  The green lines demonstrate the case 
when one can shift the radiation isocenter to the CBCT 
isocenter.  GH is the PTV, which takes into account the 
misalignment between the isocenter and the residual setup 
error.  The patient dose is )(xDlab . The dose for the cor-
responding point in the PCT is )( VxDct  . 
 
 
In Eq. (1), based on convention [12-13], we make the 
following assumptions: (1) change in beam profiles 
within the PTV region is negligible; (2) CT numbers do 
not change dramatically; and (3) surface curvature does 
not change appreciably.  Assumption (1) is not appro-
priate for very small (<1cm) field sizes due to penumbral 
effects.  In clinical implementation of single-fraction 
SRS at our institution, 3D conformal technique is used 
and the prescribed 80% isodose surface covers the whole 
PTV. Assumption (2) is valid because tissue heterogene-
ity is small in the brain, thus, the heterogeneity correc-
tion is not applied in our calculation. Assumption (3) is 
also valid given the flat surface contour of the brain rela-
tive to the small size of the beam. However, this assump-
tion may fail for places such as the inferior posterior 
head.  For a patient, we need to specify the critical dose 
and calculate the percent CTV coverage (
cD
V ) with the 
following equation, where cD is the 80% prescription 
isodose surface in this paper. 
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Here, the integration is performed over the points inside 
the CTV and H(x) is the step function that equals to 1 
when x>0 and is zero otherwise.  ),( cD DVV c

is the 
cumulative volume, which is a function of cD and the iso 
shifts. Calculating DcV for all patients, we obtain a dis-
tribution and define a threshold CV , which is 100% for 
DcV . We require that the probability of patients with 
cDc VV  is greater than a threshold value cP . In other 
words, we wish to have 
)4()(
1
1
ccDc
M
m
PVVH
M
P  
  
where M is the number of treated patients. In the limit 
when M approaches infinity, Eq. (4) can be rewritten as:  







.),()(
)()(
)(
1
1
rsrscDc
cDc
cDc
M
m
VdVdVVPVVH
VdVPVVH
VVH
M
P


           (5) 
where, )(VP

is the probability distribution of the shift 
vector V

 for all patients and can be expressed as: 
 
  rsrsrs VdVdVVPVVVVP

),()()(  .(6) 
Here ),( rs VVP

is the probability distribution for the 
systematic error ( sV

) and residual setup error ( rV

). P 
can be interpreted as the probability of successful treat-
ment. In other words, P is the probability that the pa-
tient’s CTV receives the prescription dose. In Eq. (5), all 
patients are treated identically and have the same proba-
bility distribution. This is a good approximation for 
IGRT treatments. To eliminate the effects of the patient’s 
weight or tumor size in IGRT, one can divide patients 
into groups according to their weights and tumor sizes. 
In this way, a more accurate distribution can be obtained. 
In this case, )(VP

is the probability distribution for a 
specific group.  Because the derivation is the same, the 
derivation in this paper applies to both cases. To com-
plete Eq. (5), we need two functions: )(xDCT and 
)(VP

. For a 3D conformal treatment plan, the coverage 
is the objective function of our plan. That is that 
cCT DxD )( is the object function of the conformal 
treatment plan.  The exact functional form of the dose 
distribution within the PTV is actually not so important 
for the 3D conformal treatment plan. For an IMRT plan, 
CD is a prescribed dose to a tumor. Therefore, the 
CTV-PTV margin is determined mainly by the distribu-
tion function of )(VP

in Eq. (5). We assume that  
)6()
2
)()()(
exp(
)2(
1
)(),(
2
2
0
2
0
2
0
2/320



zrrzyrryxrrx
ssrs
VVVVVV
VVVVP




 
where, rzryrx VVV ,, are the components of the residual 
setup errors in three orthogonal directions. 0sV

is the 
systematic error that is fixed for a specific machine. 
zryrxr VVV 000 ,,  
are the three components of the mean 
residual setup error ( 0rV ). Here, 0sV

represents the iso 
differences between CBCT and the linac. Residual setup 
errors are included in the following cases: (1) residual 
setup error after registration and shift correction (<1mm 
in each direction); (2) original setup error that is too 
small and to be corrected.  
 
2.1. Three dimensional expansion margins for a 
single-fraction SRS case and a specific ma-
chine 
In this section, we will construct a model to obtain the 
relationship between the probability of successful treat-
ment and the margin for a single-fraction SRS case. In 
the derivation, the iso difference between the CBCT and 
the linac is designated as the systematic error.  The 
derivation methodology can also be generalized to in-
clude all those systematic errors that are constant during 
the treatment. 
  
We describe a method of determining the CTV-PTV 
margin of amount C. In a 3D uniform expansion, the 
computer will expand a distance C uniformly from the 
surface of the CTV. One can easily understand this if the 
shape of the CTV is spherical.  If cD is defined as 80% 
of the prescription dose and %100cV , and the en-
tire PTV receives dose cp DxD )( , then 
%100DcV as long as .|| CV 

  
In other words, as 
long as the displacement is less than the margin, the 
whole CTV will receive the prescription dose.  Eq. (5) 
becomes: 
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Defining 0rr VVU

  and 000 rs VVW

 , the 
above equation can be rewritten as follows: 
 
 
 
                 
 
It is clear that in Eq. (7), P is a function of C and 0W . 
Integrating Eq. (7), we obtain: 
 
 (8)
 The Solution of the above equation yields the corre-
sponding C for a fixed P . However, the nonlinear nature 
makes it difficult to obtain an analytical solution. 
 
2.2. Three-dimensional expansion for all 
machines and all patients.  
For a comparison, we will also calculate the margin for 
the case for a group of machines and all patients (single 
fraction). In this scenario, the systematic error is differ-
ent for different machines and we assume that it is a 
Gaussian function, as in previous publications. We will 
determine the margins for the case of 3D expansion. 
 For all patients and all machines, Eq. (6) can be ex-
pressed as   
)
2
)()()(
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)9(
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zsszyssyxssx
rs
VVVVVV
VVVVVV
VVP





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
 
where, ),,( 0000 zsysxss VVVV 

is the average system-
atic error; ),,( rzryrxr VVVV 

is the average setup er-
ror; and  is the standard deviation for the residual 
setup error for all machines. If the setup procedures are 
the same, we can then assume that   . Bringing 
Eq. (9) into Eq. (5), we have  
)10(])
2
exp(2
]2)[
2
)(
[exp(
)2(
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dU
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

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
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where, 
222   . The similarity between Eq. 
(10) and Eq. (8) is very clear. Here, 000 rs VVW


 
, 
which is assumed to be zero in the previous margin for-
mula. 
 
 
3. Results 
  
At this point, we have derived the relation between the 
margins and the probability that the CTV receives the 
prescribed dose for cases of 3D uniform expansion. The 
following procedures are used in the derivation of mar-
gin formula for both 3D expansions:  
 
(1): For 3D expansion, Eq. (8) is used to obtain the rela-
tion between C and   for a fixed 0W . Polynomial 
)7()
2
exp(
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1
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functions are used to fit those relations and the corre-
sponding coefficients are obtained.  
(2) Repeating the above process for different 0W ,  
those coefficients given in (1) as a function of 0W can 
also be obtained. Because of the similarity between Eq. 
(10) and Eq. (8), the derivation procedure is virtually 
identical to the case for a specific machine. 
 
3.1. 3D Uniform Expansion  
In Figure 2, the probability of successful treatment as a 
function of margin is given for the following groups of 
values: 
mmW 5.10  , mm0.1 ; mmW 5.10  ,
mm5.0 ; mmW 5.10  , mm1.0 ; 
mmW 8.00  , mm0.1 . It is clear that when 
 becomes smaller, the margin C, which yields the 
probability of success around 100%, is closer to the sys-
tematic error (1.5mm in this example). Intuitively, the 
smaller the systematic error is 
( mmW 8.00  < mmW 5.10  ), the smaller the mar-
gin becomes for the same probability of success, as indi-
cated by the red dashed line and the blue solid line in 
Figure 2.  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 2:  Treatment success probability as a function of 
margin for different combinations of systematic and setup 
errors. Blue solid line: mmW 5.10  , mm1 ; 
black solid line: mmW 5.10  , mm5.0  ; black 
dot-dashed line: mmW 5.10  , mm1.0 ; red 
dashed line: mmW 8.00  , mm1 . 
 
 
Understandably, if there is no residual setup error, then 
the margin C approaches 0W . Therefore, the general 
margin can be expressed (up to the second order in  ) 
as: 
                            
)11()()()( 20201000  WaWaWaWC 
 
where, )2,1,0)(( 0 iWai  is a function of 0
W . Note 
that 00 a because ,0WC  when .0  
Hence, 
                            
)12()()( 202010  WaWaWC   
 
If we accept P =95%, a plot of C vs. sigma is given in 
Figure 3. The specific margin function are given as:  
    
mmWwhenWC 5.11923.0894.1 0
2
0  
  
mmWwhenWC 8.01835.0092.2 0
2
0  
 
mmWwhenWC 1.00459.0655.2 0
2
0  
 
Figure 3 reveals the effects of machine systematic error 
on the CTV-PTV margin, namely, the larger the 0W , 
the larger the margin.  
 
We repeat the above process for several additional 
0W  
values.  In other words, we first calculate C vs.  for a 
different 
0W , then we use Eq. (12) to fit the curve to get 
)( 01 Wa and )( 02 Wa . Figures 4 and 5 show the be-
havior of )( 01 Wa  
and )( 02 Wa as a function of 0W , 
respectively. We have found that  
 
)13(198.0848.0424.1787.2)( 30
2
0001 WWWWa 
  
 
and 
)14(101.0379.0470.0)( 30
2
0002 WWWWa   
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 3:  Probability margin of 95% success (i.e., the 
CTV receives the prescribed dose) as a function of standard 
deviation for different systematic errors 
( )8.0,1.0,5.10 mmmmmmW  . 
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Figure 4: Behavior of the margin parameter )( 01 Wa as a 
function of 0W  
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 5: Behavior of the margin parameter )( 02 Wa as a 
function of 0W  
 
3.2. Margins for all patients and all machines. 
The derivation of margins for the cases of all patients 
and all machines is quite similar to that of margins for 
the case of one specific machine 
For a group of machines and the whole population, the 
margin for a single-fraction treatment is   
 
)15()()( 202010  WaWaWCgroup   
where, )( 01 Wa and )( 02 Wa have the same analytical 
expressions as Eq. (13) and Eq. (14). If one assumes  
00 sV and 00 rV , Eq. (15)  is reduced to: 
 
)16(787.2 groupC  
 
Here, we need to point out that 00 sV  is a very 
strong assumption that is not correct for a cancer center 
that has several IGRT machines. Treatment plan created 
by using Eq. (16) could seriously compromise the treat-
ment outcome due to incomplete coverage of the CTV. 
 
For mm5.0 , mmW 5.00  ,and mmW 2.10  , 
the corresponding margins calculated by Eq. (16) and 
Eq. (12) are given in Figure 6.   It is clear that for a 
specific machine for which mmW 5.00  , the patient 
may have undergone effective treatment but with extra 
radiation to normal tissue because of the overly larger 
margin calculated from previous margin equations than 
needed. However, patients treated using a machine for 
which mmW 2.10  may not receive a sufficient dose 
for an effective treatment because of the smaller margins 
used.  
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 6: The margin differences between cases of a specific 
machine (blue and black) and for all machines (green). 
When using the margin for all machines, patients could be 
either underdosed or overdosed, depending on the specific 
machine used. 
 
 
4. Conclusions and Discussions 
CBCT technology not only increases the accuracy of 
radiotherapy by verifying the patient position   
immediately before irradiation, but also uses the 
enhanced or confirmed geometric accuracy to review and 
potentially reduce setup margins for the design of the 
PTV. It ultimately leads to a reduction in doses to organs 
at risk (OAR) and prevents potential detrimental dose 
escalations to these organs. However, it is also well 
known that the CBCT imaging iso center is not aligned 
with the radiation center perfectly, therefore an extra 
margin is needed for the CTV-PTV margin for IGRT 
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cases. This extra margin will become important and cru-
cial when the random setup margin is very small.  
Defining suitable CTV-PTV margins is one of the most 
important tasks for medical physicists in radiation treat-
ment planning. The formula reported in previous 
publications [8,9] has been widely used in this field for 
margin determination. However, the methodology 
adopted to develop this formula is not appropriate for 
single-fraction treatments for the following reasons: 
(1) One of the assumptions used in deriving this formula 
was that the average systematic error was zero. This 
might be true when one takes an average of all machines, 
or in a hypothetical experiment consisting of many 
fractions in which a single machine exhibits an error for 
each fraction with a mean value of zero. We believe that 
neither of these assumptions is applicable to 
single-fraction treatment [16].   
(2) In a previous study [8],
 
the margin consisted of two 
terms: one was the margin for the systematic error and 
the other was the margin for the random setup error.  In 
our study, the machine systematic error is a delta 
function; therefore, the derivation procedure in the 
previous studies cannot be directly applied to our cases.  
(3) For the margin for multi-fraction treatment, it may be 
acceptable for part of the CTV to be outside of the 
radiation field for some fractions because of its 
multifractional nature. However, this is unacceptable for 
single-fraction cases.   Finally, as we pointed out earli-
er, the systematic error cannot be eliminated entirely 
using a couch correction approach because the minimum 
possible shift from the imaging console is 1mm.  
The margin definition described in this paper is 
machine-specific and more appropriate for a 
single-fraction treatment. This three dimensional  
symmetric expansion includes the nonzero systematical 
error. The formulas for symmetric expansion margins are 
given in Eq. (15) and Eq. (12). However, we should 
point out that for convenience, polynomial functions are 
used to fit the coefficients in Eq. (15) and Eq. (12).  
Other types of functions can also be used to fit our data.  
Different from previous margin formula that was derived 
for multifraction treatment and a group of machines, 
margin formulas for a specific machine have been 
proposed here for determining appropriate CTV-PTV 
margins for SRS cases. In addition, margin formulas for 
single fraction and a group of machines are also derived. 
It has been found that this nonzero machine systematic 
error makes the margin formula more complex than the 
previous margin formula.  Although in this paper, we 
have concentrated only on one type of systematic errors, 
this methodology can be easily extended to cases with 
multiple unchangeable systematic errors. Nonzero 
systematic error is explicitly included in our margin 
formulas that have never been reported before.  Our 
derivation eliminates the assumption used in previous 
derivations of margin formulas that the mean systematic 
error is zero, therefore, it  is more general for clinical 
application.  
We like to conclude our paper with following comments: 
This derivation is primarily of academic interest only 
when the required composited margin is large. Under this 
circumstance, one can either ignore this iso difference or 
add it to the originally calculated margin. However this 
approach might be an improper way to create margin if 
the composite margin is the same order of the iso differ-
ences. More importantly we should emphasize here that 
the calculation method for multi-fraction treatments 
cannot be applied to single fraction treatment, for which, 
one needs to follow the formula given in this paper. We 
will leave the three one dimension expansions and 
asymmetry expansion of CTV-PTV margin to our follow 
up paper [18]. 
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